Fentanyl Information Sheet - Drugwatch

Latest

Independent review of drugs: call for evidence, part 2

An independent review into the use and supply of illicit drugs, seeking views on how to reduce harm to individuals and society. This consultation closes at 11:59pm on 6 August 2020
May 2020 Newsletter

Latest news from SMMGP and FDAP
Free Virtual Annual Conference 2020: What does good look like during and after COVID-19?

for the NHS Substance Misuse Provider Forum.
COVID-19: Best practice for managing drug and alcohol problems

This joint RCGP and SMMGP webinar is now available to watch

Related

Clinical guidelines for use of depot buprenorphine (Buvidal®) in the treatment of opioid dependence

These guidelines have been funded by Camurus Ltd
Clinical Guidelines (2017) - "Orange Book"

Drug Misuse and Dependence - UK Guidelines on Clinical Management. 2017 edition.
Safer Prescribing in Prisons – 2nd Edition January 2019

The second edition of Safer Prescribing in Prisons has drawn on emerging evidence and responded to feedback from the first edition.
Guidance for the use and reduction of misuse of benzodiazepines

Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice by Drs Chris Ford and Fergus Law.
Supporting nurse mentors to reduce the barriers to implementing alcohol interventions and brief advice (IBA) in primary care
Naloxone supply protocol

Naloxone is a drug which temporarily reverses the effects of opioids such as heroin, methadone and morphine.
The Management of Pain in People with a Past or current history of addiction

Guidance on how to treat or manage pain in the context of a current addiction or an early, or even established recovery.
Misuse of synthetic opiods - NEPTUNE Expert Group

The misuse of synthetic opioids: harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids. Information for clinicians.

Most read

Clinical guidelines for use of depot buprenorphine (Buvidal®) in the treatment of opioid dependence

These guidelines have been funded by Camurus Ltd
FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field.
SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership.
FDAP Practitioner Directory

Federation of Drug & Alcohol Practitioners (FDAP) - directory of members.
Free resources

Free learning available on our website, click for more information.
Addiction services change lives

We support and educate the addictions workforce
Jobs

Look for jobs within the sector.
FDAP Drug and Alcohol Professional Certificate
Free Clinical Update: Special Edition

This clinical update focuses on Buvidal® (CAM2038), the new prolonged-release subcutaneous buprenorphine injection for opioid use disorder.
Medical cannabis

FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field. Read more

SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership. Read more